Shopping Cart
Remove All
Your shopping cart is currently empty
Synonyms:
| Pack Size | Price | USA Stock | Global Stock | Quantity |
|---|---|---|---|---|
| 10 mg | Inquiry | 10-14 weeks | 10-14 weeks | |
| 50 mg | Inquiry | 10-14 weeks | 10-14 weeks |
| Description | M 16209 is an orally active aldose reductase (AR) inhibitor. It effectively inhibits partially purified aldose reductase from various sources, with IC50 values of 0.12 μM for rat lens AR, 0.24 μM for bovine lens AR, 4.5 μM for bovine kidney AR, 1.2 μM for canine lens AR, and 9.3 μM for human placental AR. M 16209 is applicable in the study of metabolic diseases such as diabetes. |
| In vivo | M 16209, administered orally at a dosage of 10-30 mg/kg once daily for 6 consecutive days, can prevent galactose-induced cataracts in male Sprague-Dawley rats. Additionally, M 16209, given at the same dosage and frequency for 14 consecutive days, can improve delayed motor nerve conduction velocity in male Wistar rats with streptozotocin-induced diabetic neuropathy. |
| Molecular Weight | 359.15 |
| Formula | C11H7BrN2O5S |
| Cas No. | 128851-36-5 |
| Smiles | O=C1NC(=O)CN1S(=O)(=O)C=2OC=3C=CC=CC3C2Br |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year Shipping with blue ice/Shipping at ambient temperature. |
Dissolve 2 mg of the compound in 100 μL DMSO
to obtain a stock solution at a concentration of 20 mg/mL . If the required concentration exceeds the compound's known solubility, please contact us for technical support before proceeding.
1) Add 100 μL of the DMSO
stock solution to 400 μL PEG300
and mix thoroughly until the solution becomes clear.
2) Add 50 μL Tween 80 and mix well until fully clarified.
3) Add 450 μL Saline,PBS or ddH2O
and mix thoroughly until a homogeneous solution is obtained.
| Size | Quantity | Unit Price | Amount | Operation |
|---|

Copyright © 2015-2026 TargetMol Chemicals Inc. All Rights Reserved.